載入...
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8(+) T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
Adenoviruses are excellent immunotherapeutic agents with a unique ability to prime and boost immune responses. Recombinant adenoviruses cause immunogenic cancer cell death and subsequent release of tumor antigens for antigen presenting cells, resulting in the priming of potent tumor-specific immunit...
Na minha lista:
發表在: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Taylor & Francis
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485730/ https://ncbi.nlm.nih.gov/pubmed/26140248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1017702 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|